Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: A case report
- Cite this article as:
- Pizon, A.F. & LoVecchio, F. J. Med. Toxicol. (2007) 3: 187. doi:10.1007/BF03160938
- 185 Downloads
This case report is about reversible cardiomyopathy associated with intrathecal baclofen withdrawal. Previous literature has reported that enteral baclofen does not adequately control intrathecal baclofen withdrawal. In our case, coronary atherosclerosis did not play a role in the development of the cardiomyopathy. However, reinstitution of intrathecal baclofen promptly resulted in improvement. One could hypothesize that myocardial stunning from sympathetic hyperactivity led to a similar cardiomyopathy reported with catecholamine excess or acute sympathomimetic poisoning.